Polypharmacy and excessive polypharmacy in community-dwelling middle aged and aged adults between 2011 and 2015.

Laura HellemansShauni NuytsJulie HiasMarjan van den AkkerGijs Van PottelberghXavier RygaertIsabel SprietBert VaesJos TournoyLorenz Van der Linden

Published in: International journal of clinical practice (2021)

The prevalence of polypharmacy increased between 2011 and 2015. Polypharmacy and excessive polypharmacy patients appeared to differ based on our observations of characteristics, drug therapy and outcomes. Age, female gender, number of chronic diseases and number of general practitioner contacts were associated with polypharmacy.

Keyphrases

adverse drug
community dwelling
end stage renal disease
newly diagnosed
chronic kidney disease
weight gain
emergency department
risk factors
mental health
prognostic factors
peritoneal dialysis
stem cells
mesenchymal stem cells
adipose tissue
body mass index
bone marrow
drug induced